Examining risk of suicide and use of ACE inhibitors, ARBs


What The Study Did:

Associations between risk of suicide and medications widely used in the management of high blood pressure, chronic kidney disease, heart failure and diabetes (angiotensin-converting enzyme inhibitors and angiotensin receptor blockers) were examined in this observational study.


To access the embargoed study:

Visit our For The Media website at this link

https:/

/

media.

jamanetwork.

com/


Authors:

Tony Antoniou, Pharm.D., Ph.D., of St. Michael’s Hospital in Toronto, is the corresponding author.

(doi:10.1001/jamanetworkopen.2019.13304)


Editor’s Note:

The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

###


Media advisory:

The full study and commentary are linked to this news release.


Embed this link to provide your readers free access to the full-text article

This link will be live at the embargo time:

http://jamanetwork.

com/

journals/

jamanetworkopen/

fullarticle/

10.

1001/

jamanetworkopen.

2019.

13304?utm_source=

For_The_Media&utm_medium=

referral&utm_campaign=

ftm_links&utm_term=

101619


About JAMA Network Open:

JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. Every Wednesday and Friday, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

This part of information is sourced from https://www.eurekalert.org/pub_releases/2019-10/jn-ero101519.php

JAMA Network Media Relations

mediarelations@jamanetwork.org
@JAMANetworkOpen

Leave a Reply

Your email address will not be published. Required fields are marked *